ERBB2 and breast cancer: In breast cancer, the TCGA study reported that 1% of the 773 breast cancer tumors tested have focal amplification of the region containing the FOXA1 genomic locus, consisting of six ER+ and two HER2 tumors (TCGA, 2012).